The live attenuated polio vaccine market size has seen formidable growth in recent years, with an increase from $1.85 billion in 2024 to an expected $2.00 billion in 2025.

Live attenuated vaccines are antigenic substances composed of a viable (living) pathogen, such as a virus or bacterium. The pathogen is altered so that it is less virulent or avirulent (attenuated).

The U.S. Centers for Disease Control and Prevention has accepted recommendations made by a panel of vaccine experts in April, ...

After recent moves by the US Department of Health and Human Services to restrict the approval and use of some vaccines — and ...

It was only in February 2024 that Valneva monetized a PRV obtained from the FDA approval of the U.S.’s first approved chikungunya vaccine, Ixchiq, for $103 million. The general understanding at ...

However, another vaccine, a live-attenuated, cold-adapted influenza vaccine (LAIV) has been licensed since 2003 in the USA, and is now recommended for immunization of healthy individuals aged 2 ...

HHS Secretary Robert F. Kennedy Jr. fired the previous roster of the CDC's vaccine advisers on Monday.

Health Secretary Robert F. Kennedy Jr. dismissed 17 members of a CDC vaccine advisory committee. Kennedy Jr. cited restoring public trust as the reason for the dismissals, despite his history of ...

Health and Human Services Secretary Robert F. Kennedy Jr.’s unprecedented shake-up of a key federal vaccine advisory panel ushered in appointees who have expressed skepticism about the value and ...

People who have documentation of receiving LIVE measles vaccine in the 1960s do not need to be revaccinated," the CDC wrote. "Most people don't know if they got the killed vaccine during this time.